This comment is more insightful than it may appear initially. It looks like the 5% drop is in comparison to the pre-Ozempic spending. To what extent is the cut on spending monetary i.e. "I am spending more on this drug and will cut back my other expenses." Sure, Ozempic will kill the cravings, and that is probably the main driver, but from a 5000 foot view, this is using money to buy drugs instead of foods. In a very abstract way, it's the same as buying amphetamines to lose weight, just with a different (arguably smaller) set of side effects.

Also, I can't find the comparison in the study to spending by non-Ozempic households. Is it possible that they decreased their spending during the time frame too, for other economic reasons? All this to say is that I think the story is more complex than the headline indicates.

> "I am spending more on this drug...

I'm in the UK and got my ADHD diagnosis on the NHS (well, via Right To Choose) so the maximum I'll ever pay for my medication is about US$150/year. [1]

If I had a private diagnosis I'd be paying about half that a month for the same medication.

Anyone with a BMI over 35 is likely to qualify for GLP-1 type drugs on the NHS too. Not sure how long they'll keep prescribing them to you if you take them and lose lots of weight. Most people I know on GLP-1 type things are paying lots (US$200 or more) a month privately.

1. £114.50 for a Prepayment Certificate covering all prescriptions for a year: https://www.nhsbsa.nhs.uk/help-nhs-prescription-costs/nhs-pr...